Arkolith/Insider Trading/IMVT/Form 4

Pande Atul

DirectorImmunovant, Inc. (IMVT) · full profile →Form 4 · filed May 20, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$192K
Net Open-Market Flow
-$192K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 20, 2026Option exercise(M)6K$8.43$51K123K
May 20, 2026Sell(S)6K$32.00$192K117K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 20, 2026Option exercise(M)6K—$0270K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001643071-26-000004) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML